NUCLEOLIN and lung cancer: Overall, the nucleolin-binding F3-peptide targeted liposomes (F3-L[Dox]) always demonstrated either improved cytotoxicity relative to non-targeted counterparts, regardless of the incubation time and the lung cancer cell line tested, or similar (p > 0.05) to free-Dox.